Accenture PLC (ACN.N)

ACN.N on New York Stock Exchange

81.07USD
12:00pm EDT
Price Change (% chg)

$-0.55 (-0.67%)
Prev Close
$81.62
Open
$81.46
Day's High
$81.54
Day's Low
$81.00
Volume
174,826
Avg. Vol
594,872
52-wk High
$85.87
52-wk Low
$69.79

ACN.N

Chart for ACN.N

About

Accenture plc (Accenture) is engaged in providing management consulting, technology and outsourcing services. The Company’s business is structured around five operating groups, which together consists of 19 industry groups serving clients in industries globally. The Company’s segment includes Communications, Media & Technology,... (more)

Overall

Beta: 1.22
Market Cap (Mil.): $54,775.34
Shares Outstanding (Mil.): 671.10
Dividend: 0.93
Yield (%): 2.28

Financials

  ACN.N Industry Sector
P/E (TTM): 19.25 18.92 24.84
EPS (TTM): 4.24 -- --
ROI: 36.44 8.78 7.83
ROE: 53.28 10.93 11.42
Search Stocks

UPDATE 2-China anti-trust regulator conducts new raids on Microsoft, Accenture

* Investigation for suspected anti-monopoly law violations

06 Aug 2014

China anti-trust regulator conducts new raids on Microsoft and partner Accenture

BEIJING, Aug 6 - A Chinese anti-trust regulator conducted new raids on Microsoft Corp and partner in China Accenture PLC, the agency said on its website on Wednesday, after saying last week Microsoft is under investigation for anti-trust violations.

06 Aug 2014

Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO - The Netherlands’ Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

05 Aug 2014

UPDATE 1-Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO, Aug 5 - The Netherlands' Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

05 Aug 2014

Philips, Accenture test brain-controlled system for ALS patients

SAN FRANCISCO, Aug 5 - The Netherlands' Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, live more independently.

05 Aug 2014

UPDATE 1-Britain sets out shale rules with new oil, gas licensing round

* Shale development still 5-10 years away-Accenture (Recasts, adds detail, quote)

28 Jul 2014

Accenture trims profit forecast as margins come under pressure

- Accenture Plc , a consulting and outsourcing services provider, cut the top end of its full-year earnings forecast as margins come under pressure, taking the shine off a rebound in its consulting business that boosted quarterly revenue.

26 Jun 2014

U.S. top court rejects Accenture trade secrets appeal

WASHINGTON, June 9 - The U.S. Supreme Court on Monday left in place a $44 million damages award that Wellogix Inc won against Accenture Plc over alleged trade secrets theft.

09 Jun 2014

Accenture warns consulting business to remain weak

- Accenture Plc warned that weakness in its consulting business that hurt second-quarter results would carry on though the year, sending its shares down as much as 8 percent.

27 Mar 2014

Accenture revenue misses estimates on lower consulting demand

March 27 - Accenture Plc, recently chosen as the lead contractor for the Obamacare enrollment website, reported a smaller-than-expected 1 percent rise in quarterly revenue due to lower demand in its consulting business.

27 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks